Human papillomavirus infection: Etiopathogenesis, molecular biology and clinical manifestations;Infecção pelo papilomavírus humano: Etiopatogenia, biologia molecular e manifestações clínicas

Anais Brasileiros de Dermatologia

Volumn 86, Issue 2, 2011, Pages 306-317

  Leto, Maria das Graças Pereira ^a   Porro, Adriana Maria ^a   dos Santos Júnior, Gildo Francisco ^a   Tomimori, Jane ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

DNA viruses; Papillomavirus infections; Warts

Indexed keywords

CAPSID PROTEIN; CAPSID PROTEIN L1; DEOXYRIBONUCLEOTIDE TRIPHOSPHATE; DNA FRAGMENT; GLYCOPROTEIN E1; OLIGONUCLEOTIDE; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

AGAR GEL ELECTROPHORESIS; ALPHAPAPILLOMAVIRUS; BASAL CELL CARCINOMA; BENIGN TUMOR; BETAPAPILLOMAVIRUS; BOWEN DISEASE; BOWENOID PAPULOSIS; CELL IMMORTALIZATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL FEATURE; CONDYLOMA ACUMINATUM; DISEASE ASSOCIATION; DISEASE COURSE; DNA TRANSCRIPTION; DOT HYBRIDIZATION; EPIDERMODYSPLASIA VERRUCIFORMIS; FOCAL EPITHELIUM HYPERPLASIA; GAMMAPAPILLOMAVIRUS; GENE; GENE AMPLIFICATION; GENE SEQUENCE; GENITAL TRACT CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 10; HUMAN PAPILLOMAVIRUS TYPE 101; HUMAN PAPILLOMAVIRUS TYPE 103; HUMAN PAPILLOMAVIRUS TYPE 107; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 12; HUMAN PAPILLOMAVIRUS TYPE 13; HUMAN PAPILLOMAVIRUS TYPE 14; HUMAN PAPILLOMAVIRUS TYPE 15; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 17; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 19; HUMAN PAPILLOMAVIRUS TYPE 2; HUMAN PAPILLOMAVIRUS TYPE 20; HUMAN PAPILLOMAVIRUS TYPE 21; HUMAN PAPILLOMAVIRUS TYPE 22; HUMAN PAPILLOMAVIRUS TYPE 23; HUMAN PAPILLOMAVIRUS TYPE 24; HUMAN PAPILLOMAVIRUS TYPE 25; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 27; HUMAN PAPILLOMAVIRUS TYPE 28; HUMAN PAPILLOMAVIRUS TYPE 29; HUMAN PAPILLOMAVIRUS TYPE 3; HUMAN PAPILLOMAVIRUS TYPE 30; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 32; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 34; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 36; HUMAN PAPILLOMAVIRUS TYPE 37; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 4; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 41; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 43; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 47; HUMAN PAPILLOMAVIRUS TYPE 48; HUMAN PAPILLOMAVIRUS TYPE 49; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPE 50; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 55; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 57; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 60; HUMAN PAPILLOMAVIRUS TYPE 61; HUMAN PAPILLOMAVIRUS TYPE 63; HUMAN PAPILLOMAVIRUS TYPE 64; HUMAN PAPILLOMAVIRUS TYPE 65; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 67; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 69; HUMAN PAPILLOMAVIRUS TYPE 7; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 72; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 74; HUMAN PAPILLOMAVIRUS TYPE 75; HUMAN PAPILLOMAVIRUS TYPE 76; HUMAN PAPILLOMAVIRUS TYPE 77; HUMAN PAPILLOMAVIRUS TYPE 78; HUMAN PAPILLOMAVIRUS TYPE 8; HUMAN PAPILLOMAVIRUS TYPE 80; HUMAN PAPILLOMAVIRUS TYPE 81; HUMAN PAPILLOMAVIRUS TYPE 82; HUMAN PAPILLOMAVIRUS TYPE 83; HUMAN PAPILLOMAVIRUS TYPE 84; HUMAN PAPILLOMAVIRUS TYPE 86; HUMAN PAPILLOMAVIRUS TYPE 87; HUMAN PAPILLOMAVIRUS TYPE 88; HUMAN PAPILLOMAVIRUS TYPE 89; HUMAN PAPILLOMAVIRUS TYPE 9; HUMAN PAPILLOMAVIRUS TYPE 91; HUMAN PAPILLOMAVIRUS TYPE 92; HUMAN PAPILLOMAVIRUS TYPE 93; HUMAN PAPILLOMAVIRUS TYPE 94; HUMAN PAPILLOMAVIRUS TYPE 95; HUMAN PAPILLOMAVIRUS TYPE 96; HYBRIDIZATION; IN SITU HYBRIDIZATION; INCUBATION TIME; KERATINOCYTE; LIFE CYCLE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOLECULAR BIOLOGY; MUCOSA; MUPAPILLOMAVIRUS; NONHUMAN; NUPAPILLOMAVIRUS; PAPILLOMAVIRUS INFECTION; PENIS CANCER; PHYLOGENY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PREVALENCE; RARE DISEASE; REVIEW; SEROTYPE; SKIN; SKIN CANCER; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VERRUCA PLANTARIS; VERRUCA VULGARIS; VERRUCOUS CARCINOMA; VIRION; VIRUS CELL TRANSFORMATION; VIRUS CLASSIFICATION; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS TYPING; VULVA CANCER; WART VIRUS;

HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; SKIN NEOPLASMS; TUMOR VIRUS INFECTIONS; WARTS;

EID: 79960161897     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962011000200014     Document Type: Review

References (50)

1. Crawford LV, Crawford EM. A comparative study of polyoma viruses. Virology. 1963;21:258-263.
2. Zur Hausen H. Human Papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol. 1977;78:1-30.
3. de Villiers EM, Wagner D, Schneider A, Wesch H, Miklaw H, Wahrendorf J, et al. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet. 1987;2: 703-706.
4. de Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur Hausen H. Classification of papillomaviruses. Virology. 2004;324:17-27.
5. Doorbar J. The papillomaviruses life cycle. J Clin Virol. 2005;32:Suppl1:S7-S15.
6. Syrjanen SM, Syrjanen KJ. New concepts on the role of human papillomaviruses in cell cycle regulation. Ann Med. 1999;31:175-187.
7. Orth G, Favre M. Human papillomaviruses. Biochemical and biologic properties. Clin Dermatol. 1985;3:27-42.
8. Hazard K. Cutaneous Human Papillomaviruses [Thesis]. Malmo: Lund University; 2007.
9. Antonsson A, Forslund O, Ekberg H, Sterner G, Hanson BG. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of theses viruses. J Virol. 2000;74:11636-1141.
10. Bernard HU. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol. 2005;32S:S1-S6.
11. Sterling, JC. Viral infections. In: Burns T, Breathnach S, Cox N, Griffiyths C, ed. Textbook of Dermatology. 7 ed. Oxford: Blackwell Science; 2004. p. 25-60.
12. Molijn A, Kleter B, Quint W, Van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol. 2005;32S:S43-S51.
13. Majewski S, Jablonska S. Human papillomaviruses-associated tumors of the skin and mucosa. J Am Acad Dermatol. 1997;36:658-659.
14. Hengge UR. Papillomavirus diseases. Hautarzt. 2004;55:841-851.
15. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000;143:614-618.
16. Kilkenny M, Marks R. The descriptive epidemiology of warts in the community. Aust J Dermatol. 1996;37:80-86.
17. Jablonska S, Majewski S, Obalek S, Orth, G. Cutaneous wart. Clin Dermatol. 1997;15:309-319.
18. Tyring SK. Human papillomavirus infections: epidemiology, pathogenesis, and host immune response. J Am Acad Dermatol. 2000;43:S18-S26.
19. Xu X, Erickson L, Chen L, Elder DE. Diseases caused by viruses - In: Elder DE, Elenitsas R, Johnson Jr BL, Murphy G F, Xu X. Ed - Lever's Histopathology of the skin. 10 ed. Philadelphia: Lippincott-Williams & Wilkins; 2008. p. 649-652.
20. Berman A, Winkelmann RK. Involuting common warts. J Am Acad Dermatol. 1980;3:356-62.
21. Rubben A, Krones R, Schwetschenau B, Grussendorf-Conen E-I. Common warts from immunocompetent patients show the same distribution of human papilloma-viruses types as common warts from immunocompromised patients. Br J Dermatol. 1993;128:264-270.
22. Rubben A, Kalka K, Spelten B, Grussendorf-Conen E-I. Clinical features and age distribuition of patients with HPV 2/27/57- induced common warts. Arch Dermatol Res. 1997;289:337-340.
23. Wilson CAB, Holmes SC, Campo MS, White SI, Tillman D, Mackie RM, et al. Novel variants of human papillomavirus type 2 in warts from immunocompromised individuals. Br J Dermatol. 1989;121:571-576.
24. Iftner A, Klug SJ, Garbe C, Blum A, Stancu A, Wilczynski S P, et al. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmuno-suppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res. 2003;63:7515-7519.
25. Hagiwara K, Uezato H, Arakaki H, Nonaka S, Nonaka K, Nonaka H, et al. A genotype distribuition of human papillomaviruses detected by polymerase chain reaction and direct sequencing analysis in a large sample of common warts in Japan. J Med Virol. 2005;77:107-112.
26. Keefe M, Al-Ghamdi A, Coggon D, Maitland NJ, Egger P, Keefe CJ, et al. Cutaneous warts in butchers [see coments]. Br J Dermatol, 1994;130:9-14.
27. Lai J Y, Doyle RJ, Bluhm JM, Johnson JC. Multiplexed PCR genotyping of HPVs from plantaris verrucae. J Clin Virol. 2006;35:435-441.
28. Egawa K, Honda Y, Inaba Y, Ono T. Pigmented viral warts: a clinical and histopatho-logical study including human papillomavirus type. Br J Dermatol. 1998; 138: 381-389.
29. Orth G. Human Papillomaviruses Associated with Epidermodisplasia Verruciformis in Non-Melanoma Skin Cancers: Guilty or Innocent? J Invest Dermatol. 2005;125: 12-13.
30. de Oliveira WRP, Festa Neto C, Rady PL, Tyring SK. Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Dermatol Venereal. 2003;17:394-398.
31. Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papilloma viruses contribute to malignant and benign epidermal proligerations? Arch Dermatol. 2002;138:629-654.
32. Berkhout RT, Bouwes-Bavinck JN, Ter-Schegget T. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol. 2000;38:2087-2096.
33. Sterling JC. Human papillomaviruses and skin cancer. J Clin Virol. 2005;32S:S67-S71.
34. Derancourt C, Mougin C, Chopard-Lallier M, Coumes-Marquet S, Drobacheff C, et al. Oncogenic human papillomaviruses in extra-genital Bowen disease revealed by in situ hybridization. Ann Dermatol Venereol. 2001; 128: 715-718.
35. Zheng S, Adachi A, Shimizu M, Shibata SI, Yasue S, Sakakibara A, et al. Human papillomaviruses of the mucosal type are present in some cases of extragenital Bowen's disease. Br J Dermatol. 2005;152:1243-1247.
36. Asgari MM, Kiviat NB, Critchlow CW, Stern JE, Argenyi ZB, Raugi GJ, et al. Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol. 2008;128:1409-1417.
37. Harwood CA, Proby CM. Human papillomavirus and non-melanoma skin cancer. Curr Opin Infect Dis. 2002;15:101-114.
38. Forslund O, Ifner T, Andersson K, Lindelo B, Hradil E, Nordin P, et al. Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis. 2007;196:876-883.
39. Harwood CA, Surentheran T, Mcgregor JM, Spink PJ, Leigth IM, Breuer J, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosup-pressed and immunocompetent individuals. J Med Virol. 2000;61:289-297.
40. Alam M, Caldwell J, Eliezri Y. Human papillomavirus associated digital squamous cell carcinoma. Literature review and report of 21 new cases. J Am Acad Dermatol. 2003;48:385-393.
41. Vera-Iglesias E, García-Arpa M, Sánchez-Caminero P, Romero-Aguilera G, De La Calle C. Focal epithelial hyperplasia. Actas Dermosifiliogr. 2007;98:621-623.
42. Chan PKS, Luk ACS, Luk TNM, Lee K F, Cheung JLK, Ho KM, et al. Distribuition of human papillomavirus types in anogenital warts of men. J Clin Virol. 2009;44:111-114.
43. Asato Y, Taira K, Yamamota Y, Uezato H. Detection of human papillomavirus type 11 in a case of Buschke-Löwenstein tumor. Eur J Dermatol. 2008;18:329-331.
44. Hama N, Ohtsuka T, Yamazaki S. Detection of mucosal human papilloma virus DNA in bowenoid papulosis, Bowen's disease and squamous cell carcinoma of the skin. J Dermatol. 2006; 33:331-337.
45. Bonvicini F, Venturoli S, Ambretti S, Paterini P, Santini D, Ceccarelli C, Zerbini M, Musiani M. Presence and type of oncogenic papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma. J Med Virol. 2005;77: 102-106.
46. Wieland U, Jurk S, Weenborn S, Krieg T, Pfister H, Ritzkowsky A. Erythroplasia of Queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Inv Dermatol. 2000; 115: 396-401.
47. de Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribuition of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer. 2009;124:1626-1636.
48. Heideman DAM, Waterboer T, Pawlita M, Van Diemen PD, Nindl I, Leijte JA, et al. Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol. 2007;25:4550-4556.
49. Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527.
50. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342-350.